Company
United StatesPublic company, NASDAQ: HSICHenry Schein Inc. (NASDAQ: HSIC), Denver, PA – FDA Inspections
Inspection records and compliance data for Henry Schein Inc. in Denver, Pennsylvania. 3 FDA inspections on record, last inspected April 02, 2026. Publicly traded as NASDAQ: HSIC.
Company Profile
This profile covers Henry Schein Inc. based in Denver, Pennsylvania, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected September 26, 2019. Last inspected April 2, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 2, 2026 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1311236 |
| September 22, 2025 | Not classified | Biologics | 1293588 |
| September 26, 2019 | Not classified | Medical Devices & Rad Health | 1123976 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Henry Schein Inc.
Stock ticker
HSIC
Exchange
NASDAQ
Share price
$86.14
Market cap
$9.5B
Price as of
November 13, 2026
FEI Number
1000143438
Address
41 Weaver Rd, Denver, Pennsylvania 17517, United States
Country
United States
ID: 51ce2a50-d24e-4b65-a6db-c1c98e7b2fe7